Connect Biopharma (CNTB) CEO details stock option and share holdings
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Connect Biopharma Holdings Ltd Chief Executive Officer Barry D. Quart filed an initial ownership report showing a mix of stock options and ordinary shares. He holds employee stock options over 2,658,734, 432,392, and 700,000 ordinary shares with exercise prices of $1.77, $0.97, and $2.69, expiring between 2034 and 2035. The options vest over four years, with portions vesting on the first anniversary of grant and the balance vesting monthly thereafter, subject to continuous service. Quart also reports direct ownership of 95,147 ordinary shares and indirect ownership of 128,887 ordinary shares through a joint account with his spouse.
Positive
- None.
Negative
- None.
Insider Trade Summary
5 transactions reported
Mixed
5 txns
Insider
Quart Barry D
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Employee Stock Option (Right to Buy) | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Employee Stock Option (Right to Buy) — 2,658,734 shares (Direct);
Ordinary Shares — 95,147 shares (Direct);
Ordinary Shares — 128,887 shares (Indirect, By Joint Account with Spouse)
Footnotes (1)
- The stock option vests and becomes exercisable over four years, with 25% vesting on the first anniversary of the date of grant, and then with respect to the remaining shares on a ratable monthly basis over the next three years, subject to continuous service with the Company as of each applicable vesting date. The stock option vests and becomes exercisable on a ratable monthly basis over four years, subject to continuous service with the Company as of each applicable vesting date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the Form 3 filing show for Connect Biopharma (CNTB) CEO Barry Quart?
The Form 3 shows Barry D. Quart’s initial beneficial ownership, including stock options over millions of ordinary shares and both direct and joint-account ordinary share holdings, establishing his equity position as a director and Chief Executive Officer.
How many Connect Biopharma stock options does CEO Barry Quart report on Form 3?
Barry Quart reports employee stock options over 2,658,734, 432,392, and 700,000 underlying ordinary shares, with exercise prices of $1.77, $0.97, and $2.69 per share, respectively, providing significant potential future equity exposure if fully vested and exercised.
What are the vesting terms of Barry Quart’s Connect Biopharma stock options?
The options vest over four years. One grant vests 25% on the first anniversary of grant, with remaining shares vesting monthly over three years. Another vests on a ratable monthly basis over four years, all subject to continuous service with the company.
When do Barry Quart’s Connect Biopharma stock options expire?
The reported employee stock options expire between 2034 and 2035. One grant expires on June 12, 2034, another on December 26, 2034, and a third on December 26, 2035, if not exercised earlier in accordance with their terms.